Pharmafile Logo
Pharmafocus logo
Advanced Search

EMA extends Avastin breast cancer licence

July 1, 2011
Sales and Marketing avastin, breast cancer, metastatic breast cancer

The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …

News

Red Door promotes Katy Pogson

July 1, 2011
Medical Communications appointment, medical communications

Katy Pogson has been promoted to associate director at Red Door Communications and joins its management team. She started at …

Appointment

IPA Best of Health Awards – results

July 1, 2011
Medical Communications Best of Health, IPA, awards, medical communications news

Langland and McCann Healthcare Sydney took home the highly coveted ‘Best of Show’ awards at the 2011 IPA Best of …

News

Almirall appoints new general manager for Germany

July 1, 2011
Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …

News

Talentmark appoints Mark Johnson

June 30, 2011
Business Services appointment, business services

Mark Johnson has joined London-based life science recruitment company Talentmark as a managing consultant. For the past eight years Mark …

Appointment

AstraZeneca signs cancer drug discovery collaboration

June 30, 2011
Research and Development AstraZeneca, PTC Therapeutics

AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …

News
Roche's Avastin (bevacizumab)

FDA advisers reject Avastin appeal

June 30, 2011
Sales and Marketing FDA, avastin

An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …

News

The growing role of regulatory affairs

June 30, 2011
Business Services, Research and Development, Sales and Marketing regulatory affairs, topra

Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …

Feature

Grindeks opens API plant in Latvia

June 30, 2011
Manufacturing and Production Grindeks, pharma manufacturing news

Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …

News
Roche's Tarceva (erlotinib)

Tarceva fails to win NICE backing

June 30, 2011
Sales and Marketing NICE, Tarceva

NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …

News
GlaxoSmithKline

GSK welcomes outside researchers to its ‘open lab’

June 29, 2011
Research and Development GSK, TB, academic alliance, malaria, open lab

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …

News

Janssen to collaborate with Jubilant on neuroscience targets

June 29, 2011
Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research

Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …

News

New medicine approvals slumped to record low in 2010

June 29, 2011
Research and Development, Sales and Marketing drug sales, new drug approvals, research

There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …

News

Introducing SHL Pharma: A Greener Approach

June 29, 2011
Manufacturing and Production auto injector, autoinjector, automation, final assembly, final packaging

SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and …

News
Press release

Treatment flexibility will improve adherence in diabetes, study suggests

June 29, 2011
Research and Development, Sales and Marketing diabetes, insulin

A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …

News

Greek debt hits pharma deliveries

June 29, 2011
Sales and Marketing Greece

The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …

News
Novartis

Regulators back Novartis’ Votubia

June 28, 2011
Sales and Marketing Novartis, Votubia, everolimus

Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …

News

BMA warns of ‘slash and burn’ health service cuts

June 28, 2011
BMA, NHS reforms

The BMA has hit out against reckless cuts to health service budgets and a ‘phoney war’ on NHS pensions. In …

News

Shire gets green light for second Replagal facility

June 28, 2011
Manufacturing and Production Replagal, Shire, Vpriv, pharma manufacturing news

The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …

News

GlaxoSmithKline fined $41m for manufacturing failings

June 28, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026